Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 40727 | 21.33 |
09:34 ET | 7170 | 21.16 |
09:36 ET | 18308 | 21.265 |
09:38 ET | 6942 | 21.24 |
09:39 ET | 9644 | 21.31 |
09:41 ET | 14126 | 21.305 |
09:43 ET | 16899 | 21.36 |
09:45 ET | 5483 | 21.46 |
09:48 ET | 29043 | 21.475 |
09:50 ET | 36850 | 21.6301 |
09:52 ET | 30251 | 21.74 |
09:54 ET | 42356 | 21.68 |
09:56 ET | 40122 | 21.8571 |
09:57 ET | 22212 | 21.975 |
09:59 ET | 29593 | 21.76 |
10:01 ET | 19335 | 21.82 |
10:03 ET | 13151 | 21.63 |
10:06 ET | 16613 | 21.88 |
10:08 ET | 114002 | 22.04 |
10:10 ET | 26991 | 22.025 |
10:12 ET | 14389 | 22.07 |
10:14 ET | 33391 | 22.07 |
10:15 ET | 14180 | 22.14 |
10:17 ET | 11967 | 22.2 |
10:19 ET | 13254 | 22.1999 |
10:21 ET | 46437 | 22.29 |
10:24 ET | 37686 | 22.29 |
10:26 ET | 24095 | 22.21 |
10:28 ET | 20574 | 22.255 |
10:30 ET | 11730 | 22.16 |
10:32 ET | 14756 | 22 |
10:33 ET | 7136 | 22.11 |
10:35 ET | 6138 | 22.2 |
10:37 ET | 40871 | 22.165 |
10:39 ET | 4135 | 22.17 |
10:42 ET | 5439 | 22.0528 |
10:44 ET | 9996 | 22.065 |
10:46 ET | 7421 | 22.1 |
10:48 ET | 18416 | 22.02 |
10:50 ET | 30631 | 21.95 |
10:51 ET | 2441 | 21.98 |
10:53 ET | 5662 | 21.96 |
10:55 ET | 17795 | 21.99 |
10:57 ET | 10313 | 21.95 |
11:00 ET | 3499 | 21.97 |
11:02 ET | 10846 | 21.94 |
11:04 ET | 56000 | 21.96 |
11:06 ET | 4729 | 21.96 |
11:08 ET | 17540 | 21.89 |
11:09 ET | 13847 | 21.915 |
11:11 ET | 15951 | 21.83 |
11:13 ET | 24468 | 21.69 |
11:15 ET | 8118 | 21.61 |
11:18 ET | 20658 | 21.66 |
11:20 ET | 65293 | 21.73 |
11:22 ET | 20996 | 21.75 |
11:24 ET | 24213 | 21.68 |
11:26 ET | 25177 | 21.5401 |
11:27 ET | 12197 | 21.55 |
11:29 ET | 9073 | 21.54 |
11:31 ET | 14466 | 21.51 |
11:33 ET | 13373 | 21.535 |
11:36 ET | 20319 | 21.54 |
11:38 ET | 2104 | 21.505 |
11:40 ET | 11981 | 21.54 |
11:42 ET | 4321 | 21.564 |
11:44 ET | 5193 | 21.58 |
11:45 ET | 7311 | 21.64 |
11:47 ET | 12951 | 21.54 |
11:49 ET | 5899 | 21.47 |
11:51 ET | 7135 | 21.45 |
11:54 ET | 2055 | 21.51 |
11:56 ET | 3593 | 21.51 |
11:58 ET | 3469 | 21.48 |
12:00 ET | 9055 | 21.52 |
12:02 ET | 3545 | 21.435 |
12:03 ET | 700 | 21.47 |
12:05 ET | 9640 | 21.47 |
12:07 ET | 5443 | 21.48 |
12:09 ET | 14405 | 21.42 |
12:12 ET | 3459 | 21.465 |
12:14 ET | 2665 | 21.44 |
12:16 ET | 5617 | 21.5 |
12:18 ET | 1300 | 21.47 |
12:20 ET | 1000 | 21.45 |
12:21 ET | 1690 | 21.41 |
12:23 ET | 3084 | 21.41 |
12:25 ET | 14479 | 21.38 |
12:27 ET | 8334 | 21.335 |
12:30 ET | 5636 | 21.35 |
12:32 ET | 5873 | 21.34 |
12:34 ET | 3954 | 21.3 |
12:36 ET | 2598 | 21.34 |
12:38 ET | 11515 | 21.29 |
12:39 ET | 1200 | 21.31 |
12:41 ET | 3727 | 21.3 |
12:43 ET | 5495 | 21.34 |
12:45 ET | 4246 | 21.35 |
12:48 ET | 2581 | 21.33 |
12:50 ET | 1516 | 21.31 |
12:52 ET | 6246 | 21.32 |
12:54 ET | 3399 | 21.37 |
12:56 ET | 7313 | 21.41 |
12:57 ET | 5862 | 21.41 |
12:59 ET | 2413 | 21.37 |
01:01 ET | 8403 | 21.38 |
01:03 ET | 12371 | 21.35 |
01:06 ET | 832 | 21.35 |
01:08 ET | 500 | 21.34 |
01:10 ET | 2000 | 21.365 |
01:12 ET | 3874 | 21.4 |
01:14 ET | 3950 | 21.4 |
01:15 ET | 1869 | 21.41 |
01:17 ET | 11549 | 21.41 |
01:19 ET | 10442 | 21.445 |
01:21 ET | 3350 | 21.45 |
01:24 ET | 7372 | 21.4 |
01:26 ET | 1200 | 21.4 |
01:28 ET | 3618 | 21.36 |
01:30 ET | 1684 | 21.38 |
01:32 ET | 4965 | 21.38 |
01:33 ET | 1999 | 21.415 |
01:35 ET | 3362 | 21.42 |
01:37 ET | 1621 | 21.44 |
01:39 ET | 5380 | 21.38 |
01:42 ET | 917 | 21.37 |
01:44 ET | 2899 | 21.36 |
01:46 ET | 2200 | 21.33 |
01:48 ET | 10764 | 21.32 |
01:50 ET | 3072 | 21.3 |
01:51 ET | 12342 | 21.25 |
01:53 ET | 4603 | 21.26 |
01:55 ET | 2551 | 21.28 |
01:57 ET | 2555 | 21.26 |
02:00 ET | 5994 | 21.21 |
02:02 ET | 10369 | 21.245 |
02:04 ET | 3145 | 21.26 |
02:06 ET | 6507 | 21.245 |
02:08 ET | 3349 | 21.25 |
02:09 ET | 5687 | 21.26 |
02:11 ET | 8612 | 21.28 |
02:13 ET | 1594 | 21.22 |
02:15 ET | 4246 | 21.21 |
02:18 ET | 1564 | 21.23 |
02:20 ET | 2540 | 21.23 |
02:22 ET | 8621 | 21.205 |
02:24 ET | 6541 | 21.25 |
02:26 ET | 2782 | 21.19 |
02:27 ET | 5645 | 21.2 |
02:29 ET | 15222 | 21.18 |
02:31 ET | 16751 | 21.16 |
02:33 ET | 1200 | 21.15 |
02:36 ET | 4684 | 21.15 |
02:38 ET | 10978 | 21.15 |
02:40 ET | 23028 | 21.23 |
02:42 ET | 2170 | 21.23 |
02:44 ET | 2911 | 21.21 |
02:45 ET | 2328 | 21.18 |
02:47 ET | 4892 | 21.18 |
02:49 ET | 6601 | 21.16 |
02:51 ET | 61064 | 21 |
02:54 ET | 32932 | 20.975 |
02:56 ET | 23077 | 21.02 |
02:58 ET | 5442 | 21.05 |
03:00 ET | 6757 | 21.045 |
03:02 ET | 13714 | 21.05 |
03:03 ET | 7087 | 21.05 |
03:05 ET | 4450 | 21.07 |
03:07 ET | 10662 | 21.0348 |
03:09 ET | 10815 | 21.01 |
03:12 ET | 6811 | 21.005 |
03:14 ET | 5611 | 21.03 |
03:16 ET | 15214 | 21.03 |
03:18 ET | 7497 | 21.04 |
03:20 ET | 18901 | 21.1099 |
03:21 ET | 21040 | 21.0531 |
03:23 ET | 8597 | 21.07 |
03:25 ET | 2806 | 21.055 |
03:27 ET | 10035 | 21.06 |
03:30 ET | 9961 | 21.02 |
03:32 ET | 22209 | 21.04 |
03:34 ET | 7933 | 21.02 |
03:36 ET | 16979 | 21.045 |
03:38 ET | 21189 | 21.05 |
03:39 ET | 9785 | 21.095 |
03:41 ET | 7779 | 21.095 |
03:43 ET | 18144 | 21.09 |
03:45 ET | 11653 | 21.1125 |
03:48 ET | 11300 | 21.165 |
03:50 ET | 12229 | 21.19 |
03:52 ET | 13799 | 21.25 |
03:54 ET | 10184 | 21.235 |
03:56 ET | 23682 | 21.215 |
03:57 ET | 15453 | 21.205 |
03:59 ET | 29851 | 21.19 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.3B | 96.1x | --- |
Twist Bioscience Corp | 3.1B | -16.0x | --- |
Arrowhead Pharmaceuticals Inc | 3.5B | -6.6x | --- |
ADMA Biologics Inc | 3.0B | -626.5x | --- |
MorphoSys AG | 2.8B | -5.5x | --- |
Denali Therapeutics Inc | 3.3B | -23.7x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.24 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 96.1x |
Price/Sales (TTM) | 11.3 |
Price/Cash Flow (TTM) | 79.2x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.